More Articles

Appropriate generics pricing improves medicines availability in Sri Lanka Generics/Research | Posted 05/09/2014

The wide availability of generics across Sri Lanka, in both private and semi-government community pharmacies, is increasing the availability and affordability of essential medicines for non-communi...

Adalimumab biosimilar has comparable pharmacokinetics to Humira Biosimilars/Research | Posted 05/09/2014

An adalimumab biosimilar (CHS-1420) from fledgling biotech company Coherus Biosciences (Coherus) has shown comparable pharmacokinetics in a pivotal clinical study.

FDA accepts applications for three-times-weekly follow-on Copaxone Biosimilars/News | Posted 05/09/2014

The US Food and Drug Administration (FDA) has accepted applications submitted by generics makers Dr Reddy’s, Sandoz (Momenta Pharmaceuticals’ development and commercialization partner), and Mylan f...

Infliximab biosimilar to be distributed by Mundipharma Biosimilars/News | Posted 05/09/2014

Celltrion’s infliximab biosimilar Remsima will be distributed in Belgium, Germany, Italy, Luxembourg, The Netherlands and UK, exclusively by Mundipharma International and its independent associated...

Generics makers comment on draft ANDA guidance Guidelines | Posted 05/09/2014

The quality of abbreviated new drug application (ANDA) submissions could be improved if the US Food and Drug Administration (FDA) spent more time with generics companies before they file an applica...

US senators call for guidance on biosimilars Biosimilars/General | Posted 05/09/2014

A growing number of US senators are calling on the country’s Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) to release guidance on key scientific policy questi...

Investor principles on biosimilars gained support Pharma News | Posted 05/09/2014

Amgen and Novartis (parent company of Sandoz, a leader in the biosimilars field) have both come out in support of a set of principles on biosimilars laid down by a coalition of 19 institutional inv...

Generics companies sue Reckitt Benckisser over generics supplies Generics/News | Posted 05/09/2014

Three generics companies are suing Reckitt Benckisser (Reckitt) for failing to provide generics supplies of its cold and flu medicine Mucinex (guaifenesin) in line with an agreement struck in 2007.